Your browser doesn't support javascript.
loading
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Harrington, Patrick; Doores, Katie J; Saunders, Jamie; de Lord, Marc; Saha, Chandan; Lechmere, Thomas; Khan, Hataf; Lam, Ho Pui Jeff; Reilly, Amy O'; Woodley, Claire; Asirvatham, Susan; Dillon, Richard; Curto-Garcia, Natalia; Sullivan, Jennifer O'; Kordasti, Shahram; Raj, Kavita; Malim, Michael H; Radia, Deepti; McLornan, Donal; Harrison, Claire; de Lavallade, Hugues.
Afiliação
  • Harrington P; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Doores KJ; School of Cancer and Pharmaceutical Science, King's College London, London, UK.
  • Saunders J; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • de Lord M; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Saha C; Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
  • Lechmere T; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Khan H; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Lam HPJ; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Reilly AO; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Woodley C; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Asirvatham S; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Dillon R; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Curto-Garcia N; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sullivan JO; Department of Medicine and Molecular Genetics, King's College London, London, UK.
  • Kordasti S; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Raj K; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Malim MH; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Radia D; School of Cancer and Pharmaceutical Science, King's College London, London, UK.
  • McLornan D; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Harrison C; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • de Lavallade H; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Blood Cancer J ; 12(4): 73, 2022 04 22.
Article em En | MEDLINE | ID: mdl-35459222
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article